Medtech grants in France

Closed

Funds PIANOFORTE’s 2026-27 continuation, an EU radiation-safety research partnership — only for its current members and any partner who joins them.

Closed

Supports international consortia so small companies can turn joint innovation into export-ready products.

Closed

Funds the coordination of up to ten existing advanced-therapy research centres into one European network, with a shared roadmap for scaling up gene and cell therapy manufacturing.

Closed

Funds industrial production of stable isotopes needed for radionuclide therapies and a more resilient European medical supply chain.

Closed

Funds a pan-European network of 10-18 startup and scaleup hubs that can pass on up to EUR 60,000 per deep-tech startup for cross-border scaling support.

Closed

Funds small and medium enterprises across Europe via Eurostars Call 11 for collaborative innovation with international partners.

Closed

Funds the next development stage, TRL 5 and up, for regenerative-medicine results that already came out of an earlier, completed EU-funded research project.

Closed

Funds implementation research that tests how schools, workplaces and other non-health settings can help prevent or manage chronic disease in low- and middle-income countries and underserved communities.

Closed

Funds around two research projects, each worth EUR 1 to 2 million, to adapt EU-built generative AI to African challenges in farming, health, cities and education.

Closed

Funds consortia that build or adapt generative AI models on large-scale multimodal health data and prove their value with at least two real biomedical use cases.

Closed

Funds research teams building interactive generative-AI agents that integrate medical imaging and health data to improve cancer diagnosis and treatment.

Closed

Funds late-stage clinical trials of vaccines, monoclonal antibodies and antivirals against a named list of lower respiratory tract infection pathogens in sub-Saharan Africa.

Closed

Funds clinical trials advancing new or improved antimalarial drug combinations toward registration and access in sub-Saharan Africa.

Closed

Funds 4 regional research networks in sub-Saharan Africa to run multi-country clinical trials and rapid outbreak-response research.

Closed

Funds clinical trials of TB vaccine candidates and licensed vaccines targeting adolescents, adults and vulnerable groups in sub-Saharan Africa.

Closed

Funds late-stage clinical trials on treating co-infections and co-morbidities in people living with HIV, not HIV itself, across sub-Saharan Africa.

Closed

Funds host institutions in sub-Saharan Africa to run Master's fellowships and short courses in epidemiology, biostatistics and infectious-disease modelling, worth up to EUR 90,000 per fellow.

Closed

Funds a platform and roadmap that connects biotech companies, health-data holders and AI Factories to accelerate AI-driven biotech innovation.

Closed

Funds research standardising how scientists detect and measure micro- and nanoplastics in the human body, and building evidence on their long-term health effects.

Closed

Pays for secure federated storage and processing capacity for Europe's shared genomic-data infrastructure, the 1+ Million Genomes initiative.

Closed

Funds tools and APIs that curate and share genomic data for research, healthcare and public-health uses across Europe's Health Data Space.

Closed

Funds R&D on rapid tests that detect chemical and biological agents, including biotoxins.

Closed

Funds R&D on vaccines and drugs that protect against chemical, biological, radiological and nuclear threats.

Closed

Funds R&D on reusable respiratory protective equipment and protection suits against chemical, biological, radiological and nuclear threats.